4EVER and PEACE results confirm superiority of BIOTRONIK Pulsar Stent

BIOTRONIK, a leading manufacturer of cardio- and endovascular medical technology, announced the results from two independent clinical studies concerning their Pulsar-18 self-expanding stent system at the CIRSE (Cardiovascular and Interventional Radiological Society of Europe) 2013 congress in Barcelona, Spain. 24-month results from the prospective, multi-center, 4EVER study were backed up by 12-month results from the multi-center, prospective PEACE registry, both of which shows Pulsar stent efficacy comparing very favorably with other bare metal stent study results. The 4EVER study investigated both the acute and long-term performance of 4 F-compatible devices in superficial femoral artery (SFA) lesions. The study examined the…
View More/Source Article